Últimas noticias sobre Stardust Power (NASDAQ:SDST) Bolsa

Stardust Power

Stardust Power Inc is a development stage manufacturer of battery-grade lithium products deigned to supply the EV industry and helping to secure America's leadership in the energy transition. They enjoy a diversified supply of lithium from American brine sources.

Stardust Power Inc

Piper Sandler analyst Brian Mullan maintains Cava Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) with a Neutral and raises the price target from $100 to $142.

News

Price Target

Analyst Ratings

CAVA

Piper Sandler Maintains Neutral on Cava Group, Raises Price Target to $142

Piper Sandler analyst Alexander Goldfarb maintains Hudson Pacific Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPP#NYSE">HPP</a>) with a Neutral and lowers the price target from $5 to $4.5.

Piper Sandler Maintains Neutral on Hudson Pacific Properties, Lowers Price Target to $4.5

RBC Capital analyst Logan Reich reiterates Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) with a Outperform and maintains $115 price target.

Reiteration

SBUX

RBC Capital Reiterates Outperform on Starbucks, Maintains $115 Price Target

Zai Lab Ltd &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZLAB#NASDAQ">ZLAB</a>) shares are trading higher by 3.45% to $27.59 during Friday&#8217;s session. The company priced a $200 million public offering of 7,843,137 shares at <a href="https://www.benzinga.com/pressreleases/24/11/b41997659/zai-lab-announces-pricing-of-public-offering-of-american-depositary-shares">$25.50 per ADS</a>.
The offering is expected to close on November 18, subject to customary conditions. The company has also granted underwriters a 30-day option to purchase an additional 1,176,470 ADSs. 
Net proceeds will be used for general corporate purposes. Goldman Sachs, Jefferies and Leerink Partners are the joint book-running managers for the offering.
Read Also: <a href="https://www.benzinga.com/government/regulations/24/11/42011035/just-before-bidens-term-ends-taiwan-semiconductor-lands-6-6-billion-in-us-funding-to-build-advanced-chip-plants">Just Before Biden&#8217;s Term Ends, Taiwan Semiconductor Lands $6.6 Billion in US Funding to Build Advanced Chip Plants</a>
<h2 class="wp-block-heading">How To Buy ZLAB Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instruments.
For example, in Zai Lab&#8217;s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, ZLAB has a 52-week high of $36.50 and a 52-week low of $13.48.

ZLAB

Why Zai Lab (ZLAB) Stock Is Trading Higher

Raymond James analyst Stephen Boland maintains Pollard Banknote (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PBL#TSX">PBL</a>) with a Outperform and raises the price target from C$44 to C$46.

TSX:PBL

Raymond James Maintains Outperform on Pollard Banknote, Raises Price Target to C$46

AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) shares are moving lower on Friday after the company reported worse-than-expected 2024 third-quarter fiscal earnings after the bell <a href="https://www.benzinga.com//node/41994523">on Thursday</a>.
What Happened: AST SpaceMobile shares fell about 13% after the company released earnings on Thursday. The earnings report included a loss of $1.10 per share, missing analyst estimates of a loss of 20 cents per share.
Furthermore, the company reported sales of $1.10 million, missing analyst estimates of $24.13 million. AST SpaceMobile reported other key pieces of financial data, including adjusted operating expenses of $45.3 million.
The company incurred about $374 million of gross capitalized property and equipment costs. It also reported $518.9 million in cash, cash equivalents and restricted cash. 
Stepping back from finances, the company announced several key agreements, such as launch service agreements with Blue Origin for launches in 2025 and 2026. These agreements will enable the orbital deployment of up to 60 Block 2 BlueBird satellites.
The company&#8217;s coverage will initially target key markets, including the U.S., Japan, and Europe.
Additionally, the company achieved initial validation of its AST5000 ASIC chip, with the necessary infrastructure in place for commissioning in 2025. The combination of the new chip and the larger Block 2 array will support enhanced data transmission.
&#8220;We achieved many significant milestones in the quarter and continue our momentum with several key pieces now in place,&#8221; said Abel Avellan, founder, chairman and CEO of AST SpaceMobile. 
&#8220;With the first five BlueBird satellites successfully unfolded and entering initial operations, our business is progressing according to plan. We&#8217;ve advanced our strategy across multiple efforts including progress on securing orbital launch capacity, growing our manufacturing capability, and expanding our customer ecosystem.&#8221;
Following the earnings report, UBS analyst Christopher Schoell maintained a Buy rating on AST SpaceMobile and raised the price target from&nbsp;$30&nbsp;to&nbsp;$31.
Related Link: <a href="https://www.benzinga.com/24/11/41961161/musk-ramaswamy-headed-doge-department-will-be-an-incredibly-challenging-endeavor-says-ted-cruzshares-this-piece-o">Ted Cruz Says Running DOGE Won&#8217;t Be A Cake Walk, Offers Reading Advice To Elon Musk</a>
ASTS Price Action: At the time of publication, AST SpaceMobile shares are moving 13.8% lower at $23.11, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Photo via Company

Movers

ASTS

What's Going On With AST SpaceMobile Stock Friday?

Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) stock is moving lower Friday after Warren Buffet&#8216;s Berkshire Hathaway <a href="https://www.benzinga.com/markets/equities/24/11/41993666/warren-buffetts-berkshire-hathaway-slashes-apple-bofa-holdings-adds-dominos-pizza-in-q3">cut its position in the company. </a>
What To Know: Buffet&#8217;s Berkshire Hathaway cut nearly all of its position in the beauty brand, according to Berkshire&#8217;s latest 13F filing.
Berkshire initially reported holding 690,106 shares in Ulta in an August filing. The latest 13F filing, released Thursday, shows its position has been reduced to 24,203 shares, a 96% cut.
The filing also indicates new positions in Domino&#8217;s Pizza Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) and Pool Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POOL#NASDAQ">POOL</a>). Berkshire acquired 1,277,256 shares of Domino&#8217;s, valued at approximately $549 million, and 404,057 shares of Pool Corp, worth about $152 million.
Furthermore, the filing shows that Berkshire continued to reduce its stake in Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Bank of America Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>). The August filing represents the company&#8217;s holdings as of June 30, while Thursday&#8217;s filing reports Berkshire&#8217;s holdings as of Sept. 30.
How To Buy Ulta Stock
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Ulta Beauty's case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Related Link: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41988194/trump-plans-to-erase-ev-tax-credit-analyst-says-its-net-bullish-calls-sell-off-wrong-knee-jerk-reaction">Trump Plans To Erase EV Tax Credit: Tesla Analyst Says It&#8217;s &#8216;Net Bullish,&#8217; Calls Sell-Off &#8216;Wrong Knee-Jerk Reaction&#8217;</a>
ULTA Price Action: At the time of writing, Ulta stock is moving 2.39% lower at $373.24, Domino&#8217;s shares are moving 2.07% higher at $444.98, Pool stock is moving 2.52% higher at $366.51, Bank of America shares are trading 0.86% higher at $46.29, and Apple stock is moving 1.45% lower at $244.88 per data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Photo via Wikimedia Commons

AAPL

POOL

ULTA

What's Going On With Ulta Beauty Shares Friday?

Spectrum Brands Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPB#NYSE">SPB</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading lower on Friday.</a>
The company reported fourth-quarter adjusted earnings per share of 97 cents, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b42004018/spectrum-brands-holdings-reports-fiscal-2024-fourth-quarter" rel="noreferrer noopener">missing the street view of $1.07</a>. Quarterly revenues were $773.7 million (+4.5%), beating the analyst consensus of $747.51 million.
Gross profit surged 17.8% to $288 million. Gross profit and margin increased due to productivity improvements, operational efficiencies, and inventory actions in the prior year, partially offset by ocean freight inflation.
Adjusted EBITDA decreased $42.6 million, driven by $32.5 million of lower investment income and $25.9 million of increased brand-focused investments, offset by gross profit improvements.
As of the fiscal year-end, the company reported a cash balance of $369 million and total liquidity of $860 million, including undrawn capacity on its cash flow revolver.
It had $578 million in outstanding debt, consisting of $496 million in senior unsecured notes and around $82 million in finance lease obligations, resulting in a net debt of approximately $209 million.
Outlook: Spectrum Brands expects low single-digit growth in reported net sales in fiscal 2025 and adjusted EBITDA to increase by mid to high single-digits. Adjusted free cash flow is expected to be approximately<a href="https://www.benzinga.com/calendars/guidance"> 50% of adjusted EBITDA.</a>
The company continues to target a long-term net leverage ratio of 2.0 &#8211; 2.5 times.
&#8220;I am excited about the upcoming year. Our focus during fiscal 2025 will be to continue the momentum we built in fiscal 2024 by investing in our brands to drive long-term growth, in innovation to expand core and adjacent categories, and in our operations to drive further cost improvement, quality and safety,&#8221; said David Maura, Chairman and Chief Executive Officer of Spectrum Brands.
Price Action: SPB shares are trading lower by 4.78% to $89.38&nbsp;at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42012197/totalenergies-joins-bp-equinor-and-shell-in-500m-drive-for-global-energy-access\" target="_blank" rel="noreferrer noopener">TotalEnergies Joins BP, Equinor, And Shell In $500M Drive For Global Energy Access</a></li>
</ul>

Earnings

Equities

Guidance

Markets

General

Spectrum Brands Stock Falls After Q4 Earnings Miss On Lower Investment Income: Details

Raymond James analyst Michael Barth reiterates Enerflex (TSX:<a class="ticker" href="https://www.benzinga.com/stock/EFX#TSX">EFX</a>) with a Outperform and raises the price target from C$12 to C$13.75.

TSX:EFX

Raymond James Reiterates Outperform on Enerflex, Raises Price Target to C$13.75

RBC Capital analyst Matthew McKellar reiterates Smurfit WestRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SW#NYSE">SW</a>) with a Outperform and maintains $58 price target.

RBC Capital Reiterates Outperform on Smurfit WestRock, Maintains $58 Price Target

Some large European and U.S. vaccine maker stocks have fallen in reaction to Robert F. Kennedy Jr.&#8217;s nomination to lead the&nbsp;Department of <a target="_blank" href="https://www.benzinga.com/government/regulations/24/11/41993115/trump-taps-rfk-jr-for-health-secretary-role-sends-5-vaccine-stocks-lower" rel="noreferrer noopener">Health and Human Services</a>.
Kennedy has been known to be against vaccines and has a track record of making false claims about vaccines, including the debunked idea that they cause autism. Scientific studies have <a target="_blank" href="https://www.benzinga.com/government/regulations/24/11/41993115/trump-taps-rfk-jr-for-health-secretary-role-sends-5-vaccine-stocks-lower" rel="noreferrer noopener">debunked this theory</a>.
Also, given his critical stance on mainstream medical practices and vaccines, U.S. Food and Drug Administration (FDA) and National Institutes of Health (NIH) employees are worried about Kennedy <a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/42009107/robert-kennedy-poised-to-lead-health-and-human-services-why-fda-nih-officials-are-nervous" rel="noreferrer noopener">being in charge</a>.
Kennedy, who received Trump&#8217;s blessing to &#8220;<a target="_blank" href="https://www.benzinga.com/markets/cannabis/24/11/41828359/could-trumps-go-wild-on-health-invite-to-rfk-jr-drive-changes-for-cannabis-and-psychedelics" rel="noreferrer noopener">go wild on health</a>,&#8221; has stated intentions to overhaul various aspects of the federal health agencies.
In a post on social media, Kennedy <a target="_blank" href="https://x.com/RobertKennedyJr/status/1857198805919138235" rel="noreferrer noopener">said</a>, &#8220;Together we will clean up corruption, stop the revolving door between industry and government, and return our health agencies to their rich tradition of gold-standard, evidence-based science. I will provide Americans with transparency and access to all the data so they can make informed choices for themselves and their families.&#8221;
On Friday, the World Health Organization also defended vaccines describing them as &#8220;absolutely critical&#8221; to global health, adding that many people alive today would not have survived <a href="https://www.benzinga.com/general/biotech/24/11/42006119/who-calls-vaccines-absolutely-critical-as-trumps-appointment-of-rfk-jr-pulls-pzifer-moderna-stocks-downhill" target="_blank" rel="noreferrer noopener">childhood without them</a>.
European vaccine player stocks declined, including&nbsp;GSK Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>), Valneva SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VALN#NASDAQ">VALN</a>), AstraZeneca Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>), <a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/41715307/biontech-variant-adapted-covid-19-vaccines-do-well-in-q3" rel="noreferrer noopener">BioNTech SE</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>), and Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>).
GSK stock fell after the company reported lower third-quarter sales, which was impacted by an 18% decline <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41624198/gsks-q3-earnings-hit-by-lower-than-expected-vaccine-sales-cautions-lower-revenue-for-2024" rel="noreferrer noopener">in vaccine sales</a>.
COVID-19 vaccine players <a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/41808252/moderna-q3-revenue-beats-on-updated-covid-19-vaccine-slashes-expenses-for-2024" rel="noreferrer noopener">Moderna Inc</a><a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/41808252/moderna-q3-revenue-beats-on-updated-covid-19-vaccine-slashes-expenses-for-2024" rel="noreferrer noopener"> </a>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>), <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41596761/pfizer-q3-earnings-revenue-and-profit-on-heightened-demand-for-paxlovid-expects-10-billion-in-202" rel="noreferrer noopener">Pfizer Inc</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), and BioNTech stock gained when the third quarter earnings surpassed estimates on increased vaccine demand.
Other vaccine players&#8217; stocks that are down include Merck &amp; Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) and Inovio Pharmaceuticals, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>).
Price Action: GSK stock is down 3.88% at $33.06, BNTX stock is down 5.18%, VALN stock is down 4.24%, AZN stock is down 2.08%, MRK stock is down 3.28%, INO stock is down 9.85% at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/11/42011035/just-before-bidens-term-ends-taiwan-semiconductor-lands-6-6-billion-in-us-funding-to-build-advanced-chip-plants" target="_blank" rel="noreferrer noopener">Just Before Biden&#8217;s Term Ends, Taiwan Semiconductor Lands $6.6 Billion in US Funding to Build Advanced Chip Plants</a></li>
</ul>
Photo by Vladimka production via Shutterstock

Biotech

Large Cap

Eurozone

Health Care

Trading Ideas

BNTX

MRNA

VALN

European And US Vaccine Stocks Are Under Pressure - Here's WHy

WIIM

NDRA

ENDRA Life Sciences shares are trading lower. The company reported Q3 financial results.

Raymond James analyst Stephen Boland maintains CI Financial (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CIX#TSX">CIX</a>) with a Outperform and raises the price target from C$22 to C$27.

TSX:CIX

Raymond James Maintains Outperform on CI Financial, Raises Price Target to C$27

ALRN

Aileron Therapeutics shares are trading lower. The company reported Q3 financial results.

RBC Capital analyst Jimmy Shan maintains Flagship Communities (TSX:<a class="ticker" href="https://www.benzinga.com/stock/MHC#TSX">MHC</a>) with a Outperform and raises the price target from C$19 to C$20.

TSX:MHC

TSX:MHC/U

RBC Capital Maintains Outperform on Flagship Communities, Raises Price Target to C$20

OMGA

Omega Therapeutics shares are trading lower after the company reported worse-than-expected Q3 EPS results and Piper Sandler cut its price target on the stock from $9 to $4.

ALUR

Allurion Technologies shares are trading lower after Chardan Capital downgraded the stock from Buy to Neutral.

BMO Capital analyst Ben Pham maintains Boralex (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BLX#TSX">BLX</a>) with a Outperform and lowers the price target from C$46 to C$45.

TSX:BLX

BMO Capital Maintains Outperform on Boralex, Lowers Price Target to C$45

VUZI

Vuzix shares are trading lower after the company reported worse-than-expected Q3 financial results.

Deep-pocketed investors have adopted a bearish approach towards Tempus AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in TEM usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Tempus AI. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 37% leaning bullish and 50% bearish. Among these notable options, 6 are puts, totaling $683,586, and 2 are calls, amounting to $99,000.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $30.0 to $55.0 for Tempus AI during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Tempus AI's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tempus AI's whale activity within a strike price range from $30.0 to $55.0 in the last 30 days. 
<h3>Tempus AI 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731687434_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TEM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$5.8</td>
<td>$4.5</td>
<td>$5.4</td>
<td>$45.00</td>
<td>$246.2K</td>
<td align="right">85</td>
<td align="right">500</td>
</tr>
<tr>
<td>TEM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.3</td>
<td>$5.0</td>
<td>$5.4</td>
<td>$45.00</td>
<td>$225.7K</td>
<td align="right">85</td>
<td align="right">462</td>
</tr>
<tr>
<td>TEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$4.7</td>
<td>$4.3</td>
<td>$4.7</td>
<td>$52.00</td>
<td>$92.5K</td>
<td align="right">206</td>
<td align="right">200</td>
</tr>
<tr>
<td>TEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/13/24</td>
<td>$9.2</td>
<td>$7.7</td>
<td>$9.2</td>
<td>$55.00</td>
<td>$63.4K</td>
<td align="right">10</td>
<td align="right">90</td>
</tr>
<tr>
<td>TEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>11/22/24</td>
<td>$23.7</td>
<td>$22.0</td>
<td>$23.0</td>
<td>$30.00</td>
<td>$50.6K</td>
<td align="right">0</td>
<td align="right">44</td>
</tr>
</tbody>
</table>

<h3>About Tempus AI</h3>
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
After a thorough review of the options trading surrounding Tempus AI, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Tempus AI</h3>
<ul>
<li>With a trading volume of 572,433, the price of TEM is up by 0.32%, reaching $56.81.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 94 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Tempus AI</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $67.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Piper Sandler lowers its rating to Neutral with a new price target of $70. 
&#x2A; Reflecting concerns, an analyst from Stifel lowers its rating to Hold with a new price target of $65.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Tempus AI with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Behind the Scenes of Tempus AI's Latest Options Trends

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Wednesday as we break down all of the biggest news this morning!



Moving stocks are new contracts and agreements, ongoing rallies, retreats from rallies and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Ampco-Pittsburgh (NYSE:<a href="https://investorplace.com/stock-quotes/ap-stock-quote/">AP</a>) stock is rocketing more than 75% on <a href="https://www.nasdaq.com/press-release/ampco-pittsburgh-subsidiaries-announce-commercial-contract-wins-and-strong-growth">commercial contract wins and backlog news</a>.</li>



<li>Vivopower (NASDAQ:<a href="https://investorplace.com/stock-quotes/vvpr-stock-quote/">VVPR</a>) shares are soaring over 54% on a <a href="https://www.nasdaq.com/press-release/vivopower-secures-extension-us-34m-loan-financing-facility-agreement-2024-07-09">new extended loan facility agreement</a>.</li>



<li>Seelos Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/seel-stock-quote/">SEEL</a>) stock is surging more than 33% alongside heavy pre-market trading.</li>



<li>Naas Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/naas-stock-quote/">NAAS</a>) shares are rising over 27% with strong early morning trading.</li>



<li>Soligenix (NASDAQ:<a href="https://investorplace.com/stock-quotes/sngx-stock-quote/">SNGX</a>) stock is increasing more than 25% as it <a href="https://investorplace.com/2024/07/why-is-soligenix-sngx-stock-up-296-today/">continues to rally</a>.</li>



<li>Cumulus Media (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmls-stock-quote/">CMLS</a>) shares are gaining over 19% without any clear news this morning.</li>



<li>Smart for Life (NASDAQ:<a href="https://investorplace.com/stock-quotes/smfl-stock-quote/">SMFL</a>) stock is climbing more than 18% after <a href="https://www.nasdaq.com/press-release/smart-life-announces-appointment-jessica-walters-chief-marketing-officer-2024-07-09">naming a new Chief Marketing Officer</a>.</li>



<li>A2Z Smart Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/az-stock-quote/">AZ</a>) shares are heading over 15% higher as they continue a recent rally.</li>



<li>Aehr Test Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/aehr-stock-quote/">AEHR</a>) stock is jumping more than 15% <a href="https://seekingalpha.com/news/4123175-aehr-test-systems-stock-up-14-after-raises-fy24-revenue-guidance-above-estimates">after increasing its guidance</a>.</li>



<li>Neuronetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/stim-stock-quote/">STIM</a>) shares are up over 13% despite a lack of news on Wednesday.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>LegalZoom.com (NASDAQ:<a href="https://investorplace.com/stock-quotes/lz-stock-quote/">LZ</a>) stock is diving 26% after <a href="https://www.nasdaq.com/press-release/legalzoom-announces-leadership-transition-2024-07-09">announcing leadership changes</a>.</li>



<li>MariaDB (NYSE:<a href="https://investorplace.com/stock-quotes/mrdb-stock-quote/">MRDB</a>) shares are tumbling more than 25% without any apparent news this morning.</li>



<li>AFC Gamma (NASDAQ:<a href="https://investorplace.com/stock-quotes/afcg-stock-quote/">AFCG</a>) stock is taking an over 20% beating on Wednesday morning.</li>



<li>Zapp Electric Vehicles (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/">ZAPP</a>) shares are retreating more than 17% <a href="https://www.marketwatch.com/amp/story/zapp-electric-shares-jump-68-after-june-china-auto-sales-report-160c0c60">following a rally yesterday</a>.</li>



<li>LogicMark (NASDAQ:<a href="https://investorplace.com/stock-quotes/lgmk-stock-quote/">LGMK</a>) stock is falling over 16% after rallying on Tuesday.</li>



<li>Sify Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/sify-stock-quote/">SIFY</a>) shares are dropping more than 16% today.</li>



<li>Stardust Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/sdst-stock-quote/">SDST</a>) stock is decreasing over 15% <a href="https://markets.businessinsider.com/news/stocks/stardust-power-jumps-45-in-pre-market-ahead-of-nasdaq-debut-1033539375">after rallying with its debut</a>.</li>



<li>Top KingWin (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcjh-stock-quote/">TCJH</a>) shares are slipping more than 14% this morning.</li>



<li>Applied DNA Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/apdn-stock-quote/">APDN</a>) stock is dipping over 14% today.</li>



<li>Connexa Sports Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/yyai-stock-quote/">YYAI</a>) shares close out our pre-market stock movers down more than 13% on Wednesday.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-july-10th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Stardust Power (SDST) has provided an update. Upon completion of a significant business combination, a company and its key stakeholders solidified ...

Stardust Power Solidifies Growth with Strategic Financial Agreements

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Just days after its listing on the Nasdaq exchange, Stardust Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/sdst-stock-quote/">SDST</a>) stock is skyrocketing. Indeed, SDST closed up by more than 140% today for seemingly no reason at all.



Stardust is a <a href="https://quantisnow.com/insight/stardust-power-shares-are-up-by-more-than-100-what's-going-on-5613023">U.S. manufacturer of battery-grade lithium products</a>. It&rsquo;s primary lithium refinery is based in Muskogee, Oklahoma. The company expects to reach a capacity of 50,000 tonnes of lithium per year by 2030.



There hasn&rsquo;t been much news related to Stardust recently, so today&rsquo;s jump certainly comes as a head scratcher. 



The newest development for the company is an <a href="https://www.tipranks.com/news/company-announcements/stardust-power-solidifies-growth-with-strategic-financial-agreements">update that Stardust provided last week</a> on the completion of a business combination between the company and its &ldquo;key stakeholders&rdquo; made through several strategic agreements. The agreements essentially serve to give some stockholders additional registration rights for company stock and warrants.



Still, that&rsquo;s not exactly a rally trigger by most standards. 



<h2>SDST Stock Soars Just a Week After Going Public</h2>



As mentioned, Stardust is relatively new to Wall Street. Just last week, on July 11, founder and CEO Roshan Pujari rang the opening bell at the Nasdaq to celebrate the firm&rsquo;s new listing. Along with expressing excitement over its new publicly traded status, Pujari shared some of the company&rsquo;s <a href="https://www.stocktitan.net/news/SDST/stardust-power-to-ring-the-nasdaq-stock-market-opening-aoh953hixlnn.html">promising goals and expectations going forward</a>.



&ldquo;Bolstering domestic lithium production is a critical national security priority for the United States, and we are aligned with the government to meet this demand and help our country achieve lithium independence,&rdquo; Pujari said. &ldquo;Already, we are expected to be eligible for up to&nbsp;$257 million&nbsp;in state incentives for our strategically central 66-acre facility build-out in Oklahoma, and there are many federal incentive programs Stardust Power may be eligible for under the Department of Energy and the Department of Defense.&rdquo;



After today&rsquo;s jump, SDST stock is trading for about $24.50 per share, up from about $11 at the start of the day. While it&rsquo;s unclear what&rsquo;s driving this upshot, fans of SDST are likely thrilled regardless.



On the date of publication, Shrey Dua did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>With degrees in economics and journalism, Shrey Dua leverages his ample experience in media and reporting to contribute well-informed articles covering everything from financial regulation and the electric vehicle industry to the housing market and monetary policy. Shrey&rsquo;s articles have featured in the likes of Morning Brew, Real Clear Markets, the Downline Podcast, and more.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/stardust-power-sdst-stock-pops-140-days-after-debut-what-to-know/">Stardust Power (SDST) Stock Pops 140% Days After Debut. What to Know.</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Stardust Power (SDST) Stock Pops 140% Days After Debut. What to Know.

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into this morning and we have all of the hottest news worth checking out on Thursday!



Moving stocks this morning are an acquisition deal, a clinical trial launch, earnings reports and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Chuy&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/chuy-stock-quote/">CHUY</a>) stock is rocketing more than 46% on a <a href="https://www.nasdaq.com/press-release/darden-restaurants-acquire-chuys-holdings-inc-approximately-605-million-transaction">$605 million acquisition deal</a>.</li>



<li>Onconetix (NASDAQ:<a href="https://investorplace.com/stock-quotes/onco-stock-quote/">ONCO</a>) shares are soaring over 43% alongside heavy pre-market trading.</li>



<li>Apollomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/aplm-stock-quote/">APLM</a>) stock is surging more than 25% with strong early morning trading.</li>



<li>Bionomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnox-stock-quote/">BNOX</a>) shares are rising over 23% as it <a href="https://www.nasdaq.com/press-release/bionomics-initiates-affirm-1-phase-3-clinical-trial-bnc210-social-anxiety-disorder">kicks off a Phase 3 clinical trial</a>.</li>



<li>Big Tree Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/dsy-stock-quote/">DSY</a>) stock is increasing more than 18% with strong pre-market trading.</li>



<li>ZimVie (NASDAQ:<a href="https://investorplace.com/stock-quotes/zimv-stock-quote/">ZIMV</a>) shares are heading over 13% higher without any clear news on Thursday morning.</li>



<li>SAI.TECH Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/sai-stock-quote/">SAI</a>) stock is gaining more than 12% on a <a href="https://www.globenewswire.com/news-release/2024/07/18/2914992/0/en/SAI-TECH-Global-Corporation-Announces-Share-Repurchase-Program.html">share repurchase program</a>.</li>



<li>MultiMetaVerse (NASDAQ:<a href="https://investorplace.com/stock-quotes/mmv-stock-quote/">MMV</a>) shares are climbing over 11% as it continues a recent rally.</li>



<li>Psyence Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/pbm-stock-quote/">PBM</a>) stock is jumping more than 10% despite a lack of news today.</li>



<li>XWELL (NASDAQ:<a href="https://investorplace.com/stock-quotes/xwel-stock-quote/">XWEL</a>) shares are up over 10% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Leslies (NASDAQ:<a href="https://investorplace.com/stock-quotes/lesl-stock-quote/">LESL</a>) stock is diving more than 21% on <a href="https://www.nasdaq.com/press-release/leslies-inc-announces-preliminary-third-quarter-fiscal-2024-financial-results-and">preliminary earnings and guidance</a>.</li>



<li>Aptevo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/apvo-stock-quote/">APVO</a>) shares are rumbling over 13% after a massive rally yesterday.</li>



<li>Domino&rsquo;s Pizza (NYSE:<a href="https://investorplace.com/stock-quotes/dpz-stock-quote/">DPZ</a>) stock is sliding more than 13% with the release of its <a href="https://ir.dominos.com/static-files/68ecdbfc-bd1c-486a-a574-d6f54b7e5132">Q2 earnings report</a>.</li>



<li>CBL International (NASDAQ:<a href="https://investorplace.com/stock-quotes/banl-stock-quote/">BANL</a>) shares are taking an over 12% beating on Thursday morning as it retreats from a rally yesterday.</li>



<li>WiMi Hologram Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/wimi-stock-quote/">WIMI</a>) stock is dropping close to 12% after an unexpected rally yesterday.</li>



<li>Beyond Meat (NASDAQ:<a href="https://investorplace.com/stock-quotes/bynd-stock-quote/">BYND</a>) shares are falling more than 11% on <a href="https://www.wsj.com/articles/beyond-meat-engages-bondholders-for-restructuring-talks-7de6b8ae">restructuring talks with bondholders</a>.</li>



<li>American Rebel (NASDAQ:<a href="https://investorplace.com/stock-quotes/areb-stock-quote/">AREB</a>) stock is decreasing over 11% this morning after rallying on Wednesday.</li>



<li>Aditxt (NASDAQ:<a href="https://investorplace.com/stock-quotes/adtx-stock-quote/">ADTX</a>) shares are slipping more than 10% <a href="https://investorplace.com/2024/07/why-is-aditxt-adtx-stock-up-72-today/">following a rally yesterday</a>.</li>



<li>Stardust Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/sdst-stock-quote/">SDST</a>) stock is dipping over 10% <a href="https://investorplace.com/2024/07/stardust-power-sdst-stock-pops-140-days-after-debut-what-to-know/">after a surprise rally yesterday</a>.</li>



<li>GRI Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/gri-stock-quote/">GRI</a>) shares close out our pre-market stock movers down more than 9%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-july-18th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Stardust Power: Who Are They, And What Caused The Stock To Suddenly Jump 145%?

Warning: SDST is at high risk of performing badly

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Stardust Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/sdst-stock-quote/">SDST</a>) just reported results for the second quarter of 2024.<ul><li>Stardust Power reported earnings per share of -24 cents. This was below the analyst estimate for EPS of -2 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/sdst-stock-earnings-stardust-power-for-q2-of-2024/">SDST Stock Earnings: Stardust Power Misses EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SDST Stock Earnings: Stardust Power Misses EPS for Q2 2024

Brent short positions held by money managers exceed longs for first time on record

Stardust Power (SDST) announced that it has engaged MUFG Bank as lead financial advisor in relation to the Company's development of one of the larg...

Stardust Power engages MUFG as lead financial advisor

STARDUST POWER GAAP EPS of -$0.22 misses by $0.18

ADTX

AEHR

AFCG

APDN

APLM

APVO

AREB

BANL

BNOX

BOIL

BYND

CHUY

CMLS

DRIP

GUSH

HNRG

KLXE

KOLD

LAAC

LESL

LGMK

MRDB

NAAS

ONCO

SDST

SEEL

SGML

SIFY

SMFL

SNGX

STIM

TALO

TCJH

USOI

VVPR

WAVE

WFRD

WIMI

XWEL

YYAI

ZAPP

ZIMV

Contracts

Press Releases

Stardust Power Closes Business Combination and Set to Begin Trading on Nasdaq

Stardust Power to Ring the Nasdaq Stock Market Opening Bell

Commodities

Small Cap

Usha Resources Makes Discovery at the White Willow Project, Prepares for Drilling at the Southern Arm Copper-Gold VMS Property

Stardust Power Selects Primero USA to complete Definitive Engineering Study

Management

Stardust Power Names Johanna Gonzalez as Director of Investor Relations and Communications

Stardust Power Welcomes Paramita Das as Chief Strategy Officer and Senior Advisor to Chief Executive

Stardust Power Secures Exclusivity to Negotiate Licensing Arrangement for Lithium Brine Concentration Technology from KMX Technologies

Stardust Power Engages MUFG as Lead Financial Advisor for Its Battery-Grade Lithium Refinery in Oklahoma

Stardust Power Announces Third Quarter 2024 Earnings Release Date, Conference Call

Comments

Stardust Power

Noticias

Últimas noticias sobre Stardust Power (NASDAQ:SDST) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL